Home
Resources
Publications
Cisplatin Plus Norcantharidin Alter the Expression of TGF-β1/Smads Signaling Pathway in Hepatocellular Carcinoma

Cisplatin Plus Norcantharidin Alter the Expression of TGF-β1/Smads Signaling Pathway in Hepatocellular Carcinoma

K Y Li, C X Shi, J Z Huang, K L Tang

Bratisl Lek Listy. 2017;118(2):85-88.

PMID: 28814088

Abstract:

Purpose:
To investigate the effects of cisplatin plus norcantharidin on transforming growth factor (TGF)-β1/Smads signaling pathway in hepatocellular carcinoma cells.
Methods:
Hepatocellular carcinoma cells (Hep3B) were divided into four groups: control group, cisplatin 2.0 μg/ml group, norcantharidin 10 μg/ml group, and cisplatin 2.0 μg/ml plus norcantharidin 10 μg/ml group. All cells were incubated for 24 hours. Cells proliferation was assessed using cell counting kit-8. Relative mRNA expression of TGF-β1, Smad4 and Smad7 were assessed by quantitative RT-PCR. Protein expression of TGF-β1 and Smad4 were investigated by western blotting.
Results:
Cisplatin, norcantharidin and cisplatin plus norcantharidin significantly inhibited the proliferation of cells, significantly attenuated both the mRNA and protein expression of TGF-β1 and Smad7, and significantly up-regulated the mRNA and protein expression of Smad4 in Hep3B (all p < 0.05), and cisplatin plus norcantharidin exhibited powerful effects than cisplatin and norcantharidin.
Conclusions:
Cisplatin, norcantharidin and cisplatin plus norcantharidin can significantly alter the expression of TGF-β1/Smads signaling pathway and inhibit the proliferation of Hep3B cells. Cisplatin plus norcantharidin exhibited powerful effects than cisplatin and norcantharidin (Fig. 4, Ref. 23).

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP29745048	Norcantharidin		29745-04-8	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: